Cryoprecipitate use during massive transfusion: A propensity score analysis

Injury(2022)

引用 1|浏览8
暂无评分
摘要
•Cryoprecipitate is discretionally administered to “sicker” patients.•Early cryoprecipitate use during massive transfusion was not associated with reduced inpatient mortality.•Randomized controlled trials evaluating cryoprecipitate use during massive transfusion are warranted.
更多
查看译文
关键词
Cryoprecipitate,Coagulopathy,Fibrinogen,Trauma,Transfusion,Hemorrhage
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要